Comparison of inflammation-based biomarkers in metastatic testicular cancer at initial diagnosis

Canadian Urological Association Journal · Published 2026-05-04 · DOI 10.5489/cuaj.9538

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.5489/cuaj.9538

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Conflicting evidence and methodological concerns in recent meta-analyses of tranexamic acid in radical cystectomy · Canadian Urological Association Journal · 2026 · Same journal
• Prescribing patterns and impact of glucagon-like peptide-1 receptor agonists in a kidney transplant evaluation cohort in British Columbia, Canada · Canadian Urological Association Journal · 2026 · Same journal
• Case series - Selective arterial embolization for non-ischemic priapism · Canadian Urological Association Journal · 2026 · Same journal
• Poster Session 1: Oncology – Prostate (Part 1) · Canadian Urological Association Journal · 2026 · Same journal
• From one chapter to the next: Reflections on the CUA presidency · Canadian Urological Association Journal · 2026 · Same journal
• Podium Session 3: Oncology - Prostate · Canadian Urological Association Journal · 2026 · Same journal
• Podium Session 1: Endourology/Stones & BPH · Canadian Urological Association Journal · 2026 · Same journal
• Case series - Mismatch repair-deficient prostate cancer · Canadian Urological Association Journal · 2026 · Same journal
• Caregiver attitudes toward testicular tissue cryopreservation in prepubertal male cancer/HSCT patients · Canadian Urological Association Journal · 2026 · Same journal
• Randomized, multicenter trial of ureteral stent placement vs. stent omission after ureteroscopy for renal stones · Canadian Urological Association Journal · 2026 · Same journal